US Archives - Page 65 of 137 - European Medical Journal

AMJ Dermatology 2.1 2025

In this issue of AMJ Dermatology, dive into expert-led coverage of AAD 2025, including highlights on environmental dermatology, JAK…

A Year in Review from the 2025 AAD Annual Meeting

At the 2025 American Academy of Dermatology (AAD) Annual Meeting, Adela Rambi Cardones and Kevin Wang led a session highlighting top basic…

JAK Inhibitors for Atopic Dermatitis: AAD 2025

ATOPIC dermatitis (AD) is one of the most common chronic inflammatory skin diseases in the world, affecting 15–25% of children and 3–7% of…

Determinants of Therapeutic Resistance in Pediatric Atopic Dermatitis

Atopic dermatitis (AD) is a chronic skin condition affecting children, often influenced by various environmental and behavioral factors…

Updates on Melanoma and Melanocytic Neoplasms

The American Academy of Dermatology (AAD) Annual Meeting is where many of the largest breakthroughs within the field of dermatology are…

Scarring Alopecias in a Pediatric Trichology Clinic

Scarring alopecias (SA) are uncommon, and despite their morbidity, research on pediatric patients remains limited. Data on the most…

The Intersection of Climate Change, Air Pollution, and Dermatology: AAD 2025

The impact of air pollution and our changing climate on dermatologic disease is a new and emerging area of research. The American…

Concerns with Cosmetic Procedures in Skin of Color

In the United States, patients with skin of color (SOC) face significant healthcare disparities. Recognizing and addressing the…

Ethics of Treating Actinic Keratosis in Patients of Advanced Age

This ethics discussion highlights the complexities of treating actinic keratoses (AK) in elderly patients, particularly those in their…

Acrocyanosis After Immunotherapy: Vasculitis or Vasculopathy?

Acral digital ischemia associated with immune checkpoint inhibitor (ICI) use is a rare and poorly understood toxicity. The authors report…